Wohnung in Al Qasimia,Al Mahatta Building, 2 schlafzimmer, 455000 AED - 16784730
9
AED455.000
Geschätzte Zahlung AED 1,9 Tsd./Monat
Finanzierung prüfen
Al Mahatta Building, Al Qasimia, Sharjah
2 Schlafzimmer
3 Bäder
106 m²

Wohnung in Al Qasimia,Al Mahatta Building, 2 schlafzimmer, 455000 AED - 16784730

Mohamed Abdelhafiz from Elite Home Real Estate presents an exceptional investment opportunity in Gemini Tower B — discover the perfect blend of modern design and community living in Al Qasimia, Sharjah.

Gemini Tower B | Premium Residential Unit

Unit Details:
- 2 Bedrooms + Living Area
- 3 Bathrooms
- 1,141 sqft
- Modern Kitchen
- Functional Layout
- Leasehold

What the community offers:
- 24/7 Security
- Swimming Pool
- Fully Equipped Gym
- Family-Friendly Community
- Walking Areas, Cafés & Restaurants
- Nearby Retail Shops & Daily Services

Location:
- Prime Al Qasimia Location, Sharjah
- Close to Schools, Supermarkets, and Daily Services
- Easy Access to Main Roads

Price: AED 455,000

Why Gemini Tower B:
- Well-established building with excellent finishing standards
- Strong investment potential in a growing Sharjah community
- Family-friendly environment with complete amenities
- Ideal for end-users and investors alike

About Elite Home:
Elite Home is a leading real estate company with extensive experience in Sharjah. We specialize in helping buyers and tenants find their dream homes through professional and personalized consultations. Trust our team to guide you every step of the way.

For more information or to arrange a viewing, contact Mohamed Abdelhafiz at Elite Home Real Estate.

Email:
For any feedback or complaints:

Objektinformationen

  • TypWohnung
  • ZweckVerkauf
  • Referenznr.Bayut - Elitehome-S-8147
  • FertigstellungBezugsfertig
  • MöblierungUnmöbliert
  • Durchschnittsmiete
  • Hinzugefügt am8. Oktober 2026

Validierte Informationen

Validated Check Mark Icon

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Wohnung an

Gebäudeinformationen

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen